Market Size of Italy Mammography Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Market Size (2024) | USD 97.90 Million |
Market Size (2029) | USD 149.82 Million |
CAGR (2024 - 2029) | 8.88 % |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Italy Mammography Market Analysis
The Italy Mammography Market size is estimated at USD 97.90 million in 2024, and is expected to reach USD 149.82 million by 2029, growing at a CAGR of 8.88% during the forecast period (2024-2029).
The COVID pandemic had an adverse effect on market growth. The COVID-19 pandemic imposed clinicians with a special set of challenges in the management of women needing periodic screening mammography, imaging, and needle biopsy for suspect breast cancer, according to the article titled "Breast imaging and cancer diagnosis during the COVID-19 pandemic: recommendations from the Italian College of Breast Radiologists by SIRM" published in Springer Nature in July 2020. Routine outpatient breast imaging activity has frequently been severely decreased as a result of the lockdown, the requirement for social isolation, and diminished hospital resources. Determining which women can wait until the pandemic is gone, can wait a fair amount of time, or need immediate or non-reschedulable care is critical. In this situation, the Italian College of Breast Radiologists by the Italian Society of Medical Radiology (SIRM) has defined the following recommendations for patients during a lockdown: patients having a scheduled or upcoming appointment for detailed diagnostic breast imaging or needle biopsy should confirm the appointment or obtain a new one; patients who have suspect breast cancer symptoms should request non-deferrable tests at radiology services; asymptomatic women performing annual mammographic follow-up after menopause should request non-deferrable tests at radiology services. Asymptomatic women should schedule the check, ideally within 3 months of the date the check was not performed, in accordance with local organisational requirements, if they have not responded to the invitation for screening mammography after the start of the pandemic or have been informed that the screening activity has been suspended. Despite having experienced an economic collapse during the first wave of the coronavirus, the aforementioned causes are predicted to increase the demand for mammography in Italy.
Factors, such as the growing prevalence of breast cancer, technological advancements in the field of breast imaging, and the investment from various organizations in breast cancer screening campaigns. For instance, according to information from EUROPA DONNA, the European Breast Cancer Coalition, in Italy the expected number of women diagnosed with breast cancer in 2020 was approximately 55,133, and there were approximately 12,633 breast cancer-related deaths. 2020 saw an approximate 87.0 and 13.4 age-standardized incidence and mortality rate per 100,000 women. Breast density measured using a new fully automated method is positively associated with BC risk and is comparable to radiologists' visual assessment, according to Paolo Giorgi Rossi's article from 2021 titled "Validation of a new fully automated software for 2D digital mammographic breast density evaluation in predicting breast cancer risk." It is a stronger indicator of interval cancer and confirms that breast density has a discernible masking effect that lowers mammography sensitivity. These devices' cutting-edge software contributes to the segment's growth. Thus, the abovementioned factors are expected to increase market growth.
However, the risk of adverse effects from radiation exposure, and reduction in reimbursement are expected to hinder the market growth.
Italy Mammography Industry Segmentation
As per the scope of the report, mammography refers to a standard diagnostic and screening technique that is used to screen breast tissues to check the presence of a malignant tumor. The process involves the usage of low-energy X-rays for the early detection of breast cancer. Italy Mammography Market is Segmented by Product Type (Digital Systems, Analog Systems, Breast Tomosynthesis, and Other Product Types), End User (Hospitals, Specialty Clinics, and Diagnostic Centers). The report offers the value (in USD million) for the above segments.
By Product Type | |
Digital Systems | |
Analog Systems | |
Breast Tomosynthesis | |
Other Product Types |
By End User | |
Hospitals | |
Specialty Clinics | |
Diagnostic Centers |
Italy Mammography Market Size Summary
The Italy mammography market is poised for significant growth over the forecast period, driven by factors such as the increasing prevalence of breast cancer and advancements in breast imaging technologies. The market is expected to expand as a result of heightened demand for mammography services, spurred by the need for early detection and diagnosis of breast cancer. The COVID-19 pandemic initially disrupted routine screening activities, but it also underscored the importance of mammography, leading to a resurgence in demand as healthcare systems adapted to ensure continuity of care. Technological innovations, such as digital breast tomosynthesis and automated breast density evaluation, are enhancing the accuracy and effectiveness of breast cancer detection, further propelling market growth. Additionally, investments from organizations and collaborations between healthcare providers and technology companies are fostering the development and adoption of advanced mammography solutions in Italy.
Despite the promising growth trajectory, the market faces challenges, including concerns over radiation exposure and changes in reimbursement policies. However, the ongoing research and development efforts, along with the high incidence of breast cancer, are expected to mitigate these challenges and sustain market expansion. The competitive landscape is characterized by the presence of major players like GE Healthcare, Fujifilm Holdings Corporation, Siemens Healthineers AG, Carestream Health Inc., and Koninklijke Philips NV, who are actively involved in enhancing mammography technologies and expanding their market presence. Collaborative initiatives, such as those between Roche Italia, Fujifilm Italia, and the Italian National Health Service, aim to improve breast cancer screening and treatment outcomes, further supporting the market's growth prospects.
Italy Mammography Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Growing Burden of Breast Cancer
-
1.2.2 Technological Advancements in the Field of Breast Imaging
-
1.2.3 Investment from Various Organizations in Breast Cancer Screening Campaigns
-
-
1.3 Market Restraints
-
1.3.1 Risk of Adverse Effects from Radiation Exposure
-
1.3.2 Reduction in Reimbursement
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Product Type
-
2.1.1 Digital Systems
-
2.1.2 Analog Systems
-
2.1.3 Breast Tomosynthesis
-
2.1.4 Other Product Types
-
-
2.2 By End User
-
2.2.1 Hospitals
-
2.2.2 Specialty Clinics
-
2.2.3 Diagnostic Centers
-
-
Italy Mammography Market Size FAQs
How big is the Italy Mammography Market?
The Italy Mammography Market size is expected to reach USD 97.90 million in 2024 and grow at a CAGR of 8.88% to reach USD 149.82 million by 2029.
What is the current Italy Mammography Market size?
In 2024, the Italy Mammography Market size is expected to reach USD 97.90 million.